Dr. Shahriar Alizadegan, MD

Dr. Alizadegan practices at SSM Health St. Agnes Hospital - Fond du Lac in Fond Du Lac, Wisconsin, part of SSM Health Care.

Dr. Alizadegan's NPI, 1063647857, was assigned on May 21, 2009. Dr. Alizadegan graduated from Tabriz University of Medical Sciences in 1995. Dr. Alizadegan's Wisconsin license number on file is 62270.

Dr. Alizadegan's primary practice is SSM Health St. Agnes Hospital - Fond du Lac, at 430 E Division St, Fond Du Lac, WI 54935 in Fond Du Lac County. The practice phone is (920) 929-2300.

Dr. Alizadegan's primary practice is SSM Health St. Agnes Hospital - Fond du Lac in Fond Du Lac, Wisconsin, part of SSM Health Care. Dr. Alizadegan is also affiliated with Froedtert Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Alizadegan to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alizadegan practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Alizadegan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Alizadegan is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Alizadegan's licenses on file in 3 states: Wisconsin, Florida and Illinois.

Dmand AI lists amputation, carotid revascularization, heart device and aorta surgery, leg revascularization and varicose veins among the conditions Dr. Alizadegan treats.

CMS data shows 103 Medicare services from Dr. Alizadegan across 5 procedure codes in 2024, for 54 Medicare patients. Medicare paid $2,795 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Alizadegan in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alizadegan's median patient age at 75, with 37% women.

In 2024, Dr. Alizadegan wrote 28 Medicare Part D claims for 18 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $177 in total drug cost. In 2019, CMS named 27 claims across 1 drug.

Dr. Alizadegan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of leg revascularization (restoring blood flow) by Dr. Alizadegan, more than 81% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Alizadegan in 2020. 2020 was the busiest year, with 2. Dr. Alizadegan's most frequent co-authors are Thomas William Carver, MD, Matthew Isaac Goldblatt, MD and Brian D. Lewis, MD.

CMS Open Payments shows 45 general payments to Dr. Alizadegan from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Medtronic Vascular, Inc. paid the most, $2,068.

Dr. Alizadegan graduated from Tabriz University of Medical Sciences in 1995.

Dr. Alizadegan is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.